International joint venture

CULT Food Science Announces Investment and Joint Venture Plans with Culinary Medicine Company Peqish

Retrieved on:

목요일, 5월 11, 2023

CULT, International joint venture, CSE, Research, FRA, Joint venture, Organization, Transaction, OTC, Ideation, Knowledge, Food, Cryptocurrency

Under the JV Agreement, each of CULT and Peqish will initially make their contributions and fulfil their obligations to the Joint Venture within their own respective organizations and with their own personnel.

Key Points:

Under the JV Agreement, each of CULT and Peqish will initially make their contributions and fulfil their obligations to the Joint Venture within their own respective organizations and with their own personnel.
If the Joint Venture proceeds to the commercialization phase, the parties expect to form a new, equally-owned subsidiary company.
Peqish's contributions to the Joint Venture will include: insights, industry network and knowledge in the culinary medicine and clinical areas; and access to its team of clinical and scientific experts to assist the Joint Venture in conducting clinical trials and validating products that have been identified by the Joint Venture for their adherence to culinary medicine principles.
Under the Share Exchange Agreement, CULT will issue an aggregate of 1,921,500 common shares of CULT (each, a "CULT Share") to Peqish, and Peqish will issue an aggregate of 46,937 common shares of Peqish ("Peqish Shares") to CULT.

DXC Technology Completes Major Data Center Migration for the London Insurance Market

Retrieved on:

목요일, 5월 4, 2023

LONDON, May 4, 2023 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, working closely with the London Market Joint Ventures (XIS and XCS), has successfully completed a major data center migration, a key milestone in the multi-year transformation of the world's largest insurance market.

Key Points:

70 billion rows of data, 700 IT assets, and over 200 business applications successfully moved in one of world's most ambitious data center migrations
Supports transformation to a better, faster and cheaper London insurance marketplace
LONDON, May 4, 2023 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, working closely with the London Market Joint Ventures (XIS and XCS), has successfully completed a major data center migration, a key milestone in the multi-year transformation of the world's largest insurance market.
This major undertaking required critical input and coordination from several major organizations in the insurance world including Lloyd's of London, the International Underwriting Association (IUA), the Lloyd's Market Association (LMA) and the London & International Insurance Brokers Association (LIIBA).
As the world's largest insurance center, the London insurance market represents 7.6% of the global commercial (re)insurance market, employs 47,000 people across the UK, and makes up almost a quarter of the City of London's GDP.
"The scale of this data migration is extraordinary and has required intensive collaboration between DXC, the Joint Ventures, and the companies of the London insurance market," said Louise Day, Director of Operations, International Underwriting Association.

PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health

Retrieved on:

월요일, 5월 1, 2023

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Australian-based Vitura Health Limited (ASX: VIT) (“Vitura”). Following the execution of a letter of intent between Vitura and PharmAla in late February, the parties have executed definitive agreements (the "Agreements"), including for the establishment of an incorporated joint venture vehicle, Cortexa Pty Ltd ("Cortexa"), which is owned equally by Vitura and PharmAla, pursuant to the terms of a joint venture agreement (the "JV Agreement") entered into among Cortexa, Vitura and PharmAla.

Key Points:

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Australian-based Vitura Health Limited (ASX: VIT) (“Vitura”).
Following the execution of a letter of intent between Vitura and PharmAla in late February, the parties have executed definitive agreements (the "Agreements"), including for the establishment of an incorporated joint venture vehicle, Cortexa Pty Ltd ("Cortexa"), which is owned equally by Vitura and PharmAla, pursuant to the terms of a joint venture agreement (the "JV Agreement") entered into among Cortexa, Vitura and PharmAla.
Cortexa is an Australian company, jointly owned by Vitura and PharmAla and with equal board representation.
In announcing the Joint Venture, Nick Kadysh, CEO of PharmAla Biotech, said:
“In seeking a partner to be the market leading supplier of GMP manufactured MDMA and Psilocybin in Australia, we looked far and wide.

Innovative Payment Solutions Announces IPSIPay Express™, a New Business Line to Broaden IPSI’s Digital Payments Services Into the Fast-Growing Online Gaming and Entertainment Sectors

Retrieved on:

월요일, 5월 1, 2023

International joint venture, W. A. G. Payment Solutions, Velocity-addition formula, IPSI, OTCQB, Joint venture, Securities and Exchange Commission of Pakistan, Growth, Express, Online shopping

Importantly, IPSI believes that the IPSIPay Express business should be ready for launch and could begin to generate revenue for IPSI during 2023.

Key Points:

Importantly, IPSI believes that the IPSIPay Express business should be ready for launch and could begin to generate revenue for IPSI during 2023.
OpenPath, headquartered in Irvine, California provides payment solutions to companies processing large volumes of online payments.
We believe the innovative payment technology that will be at the core of IPSIPay Express will be a game changer for merchants operating in so-called “high-risk” industries like online gaming and entertainment.
William Corbett, IPSI’s Chairman and CEO commented, “We are excited by the new opportunities IPSIPay Express will provide for us.

Natuzzi S.p.A.: 2022 Fourth Quarter and Full Year Financial Results and Shareholder Letter

Retrieved on:

목요일, 4월 13, 2023

In 4Q 2022, invoiced sales from franchise stores amounted to €46.6 million, an increase of 12.8% compared to 4Q 2021.

Key Points:

In 4Q 2022, invoiced sales from franchise stores amounted to €46.6 million, an increase of 12.8% compared to 4Q 2021.
During 4Q 2022, invoiced sales from the wholesale channel amounted to €44.6 million, a decrease of (15.0%) compared to 4Q 2021.
As a consequence, during the quarter the Company reported Finance costs of (€2.7) million compared to Finance costs of (€1.5) million in 2021 fourth quarter.
The Company will host a conference call to discuss fourth quarter and full year 2022 financial results on Friday April 14, 2023, at 10:00 a.m. U.S. Eastern Time (4.00 p.m. Italy time, or 3.00 p.m. UK time).

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

Retrieved on:

금요일, 3월 24, 2023

TORONTO, March 24, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2022 and provided a corporate update.

Key Points:

Importantly, we are in the process of engaging a new Contract Research Organization (“CRO”) to oversee the Tigris trial.
The new company, i-Dialco, is exclusively focused on advancing commercialization of the SAMI and DIMI dialysis devices in the North American markets.
We anticipate our initiatives aimed at enhancing trial recruitment and enrollment will assist in completion of Tigris as expeditiously as possible.
With the establishment of i-Dialco, the previous Dialco operations were considered discontinued as at December 31, 2022.

Appia Signs Letter Agreement to Acquire up to a 70% Interest in a Prospective Brazilian Rare Earths Ionic Clay Project

Retrieved on:

화요일, 3월 7, 2023

Appia is very excited to have entered into the Letter Agreement to secure this high potential property in Brazil.

Key Points:

Appia is very excited to have entered into the Letter Agreement to secure this high potential property in Brazil.
A number of professional consultants with direct ionic clay expertise have been contacted to bring together a project team suited for this specialized project.
Appia will take the next 90 days to complete its due diligence on the properties prior to finalizing this option agreement.
"Ionic adsorption clays are the main source of the critical rare earth permanent magnet metals, dysprosium and terbium," stated Stephen Burega, President of Appia.

Navigator Holdings Ltd. Announces Additional Details For Expansion Project Under Existing Ethylene Export Terminal Joint Venture

Retrieved on:

목요일, 3월 9, 2023

Enterprise Products, Panama Canal expansion project, International joint venture, NYSE, Joint, Hand, Joint venture

NEW YORK and LONDON, March 09, 2023 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (“Navigator” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, is pleased to announce additional details regarding its expected participation in a capital project (the “Expansion Project”), previously announced on November 15, 2022, under its existing ethylene export terminal joint venture with Enterprise Products Partners L.P. ("Enterprise”) at Morgan’s Point near Houston (the “Joint Venture”).

Key Points:

NEW YORK and LONDON, March 09, 2023 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (“Navigator” or the “Company”) (NYSE: NVGS), the owner and operator of the world’s largest fleet of handysize liquefied gas carriers, is pleased to announce additional details regarding its expected participation in a capital project (the “Expansion Project”), previously announced on November 15, 2022, under its existing ethylene export terminal joint venture with Enterprise Products Partners L.P. ("Enterprise”) at Morgan’s Point near Houston (the “Joint Venture”).
The Expansion Project is expected to increase ethylene export capacity by at least 550,000 tons per year, and up to 2 million tons per year.
Potential total ethylene export capacity at Morgan’s Point is expected to be more than 3 million tons per year by the end of 2024.
The timing and expected completion date of the Expansion Project is subject to a number of risks and uncertainties commonly associated with this type of project.

Eagle Materials Reports Record Third Quarter Results With 26% EPS Growth

Retrieved on:

목요일, 1월 26, 2023

In the third quarter, we achieved record revenue of $511 million and record EPS of $3.20, and we expanded gross margins by 110 bps to 31.0%.

Key Points:

In the third quarter, we achieved record revenue of $511 million and record EPS of $3.20, and we expanded gross margins by 110 bps to 31.0%.
Third quarter performance was led by our Gypsum Wallboard business, in which margins expanded 400 bps.
During the quarter, we generated strong free cash flow and repurchased 824,000 shares of our common stock.
Heavy Materials operating earnings declined 11% to $75 million, primarily because of lower Cement sales volume partially offset by higher Cement net sales prices.

CMG CLEANTECH AGREES TO PARTNER WITH NORTH AFRICAN ENERGY COMPANY TO EXECUTE SOLAR CELL FACTORY PROJECT IN THE NORTH AFRICAN REGION.

Retrieved on:

목요일, 2월 2, 2023

Natural Resources, Regulatory News Service, Africa Scout Region (World Organization of the Scout Movement), Joint venture, International joint venture, Solar cell, NORTH, CMG, Electricity, CELL, Renewable energy

CMG CLEANTECH AGREES TO PARTNER WITH NORTH AFRICAN ENERGY COMPANY TO EXECUTE SOLAR CELL FACTORY PROJECT IN THE NORTH AFRICAN REGION.

Key Points:

CMG CLEANTECH AGREES TO PARTNER WITH NORTH AFRICAN ENERGY COMPANY TO EXECUTE SOLAR CELL FACTORY PROJECT IN THE NORTH AFRICAN REGION.
Paris, 20th January 2023, CMG CleanTech S.A (“CMG”), a clean energy and technology corporation, today announced it has agreed to the terms of a new Joint Venture with North African Energy company to build a Solar Cell Factory in the North African Region.
This privately owned energy company which designs, manufactures, constructs and assembles electricity production solutions, was founded in the late eighties and is one of the main players in the North African energy market.
By partnering with this North African energy company, CMG will be the only manufacturer of Solar Cells in the North African Region, giving the Company local market entry with advantageous tax arrangements and further opportunities to expand in this region.